<DOC>
	<DOCNO>NCT00024622</DOCNO>
	<brief_summary>This vivo positron emission tomography ( PET ) study regional cerebral dopamine blood flow normal volunteer , person Parkinson disease ( familial sporadic ) , schizophrenia spectrum disorder . The latter also sign consent NIH approve protocol 89-M-0160 , Inpatient Evaluation Neuropsychiatric Patients , PI : Jose Apud , M.D. , Ph.D . Using PET 6- [ F-18 ] Fluoro-L-dopa ( FDOPA ) ( 15 ) 0-H2O single scan session , presynaptic dopaminergic function regional cerebral blood flow ( rCBF ) assess . The kinetic rate constant ( Ki ) presynaptic dopaminergic uptake striatum region calculate . We compare Ki across subject group relate finding rCBF . Findings also relate allelic variation gene interest , determination participant sign separate consent NIH approve protocol 95-M-0150 Neurobiological Investigation Patients Schizophrenia Spectrum Disorders Their Siblings , PI : Karen F. Berman , MD . We also draw comparison subject inherit vs. sporadic Parkinson disease determine whether PET phenotype group , compare system-level , circuit-based pathophysiology across PD schizophrenia group . Each subject screen MRI rule structural abnormality also delineate area interest PET scan .</brief_summary>
	<brief_title>PET Scanning Parkinson Disease</brief_title>
	<detailed_description>This vivo positron emission tomography ( PET ) study regional cerebral dopamine blood flow normal volunteer , person Parkinson disease ( familial sporadic ) , schizophrenia spectrum disorder . The latter also sign consent NIH approve protocol 89-M-0160 , Inpatient Evaluation Neuropsychiatric Patients , PI : Daniel Eisenberg , M.D . Using PET 6- [ F-18 ] Fluoro-L-dopa ( FDOPA ) ( 15 ) 0-H2O single scan session , presynaptic dopaminergic function regional cerebral blood flow ( rCBF ) assess . The kinetic rate constant ( Ki ) presynaptic dopaminergic uptake striatum region calculate . We compare Ki across subject group relate finding rCBF . Findings also relate allelic variation gene interest , determination participant sign separate consent NIH approve protocol 95-M-0150 Neurobiological Investigation Patients Schizophrenia Spectrum Disorders Their Siblings , PI : Karen F. Berman , MD . We also draw comparison subject inherit vs. sporadic Parkinson disease determine whether PET phenotype group , compare system-level , circuit-based pathophysiology across PD schizophrenia group . Each subject screen MRI rule structural abnormality also delineate area interest PET scan .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>INCLUSION CRITERIA : Age 18 90 year Ability give inform consent Ability read write Ability give adequate medical neuropsychiatric history . PARKINSONS DISEASE : Individuals age 18 family autosomal dominant form Parkinson 's disease suspect base pedigree analysis . Each subject medical history brief neurological examination . The diagnosis probands must support accept clinical criterion : tremor , bradykinesia , responsiveness LDOPA . Equivocally affected individual also include order aid phenotypic classification risk individual show neurological sign . Individuals sporadic Parkinson 's disease also scan . These age 50 year know family history Parkinson 's disease movement disorder . PD patient admission physical exam medical history well laboratory test deem necessary basis history physical exam . SCHIZOPHRENIA : Members patient group diagnosis schizophrenia schizophrenia spectrum disorder determine SCID currently enrol NIH approve protocol 89M0160 ( Inpatient Evaluation Neuropsychiatric Patients ) receive admission workup . HEALTHY VOLUNTEERS : A large cohort healthy volunteer also PET scan . Volunteers age , gender handednessmatched patient statistical purpose . Volunteers , enrol healthy control protocol 95M0150 `` Neurobiological Investigation Patients Schizophrenia Spectrum Disorders Siblings '' receive admission workup protocol . EXCLUSION CRITERIA : Will include medical illness would affect cerebral blood flow dopamine Current pregnancy Current breast feeding Possible exposure radiation exceed RSC guideline History addiction alcohol drug Inability stay caffeine nicotinefree 4 hour Current suicidality assaultiveness History movement disorder History head injury require hospitalization History coma Inability meet general safety criterion MRI study ( determine standardize Nuclear Medicine Research ( NMR ) Center screen ) Previously demonstrate inability unwillingness comply study protocol . PARKINSONS DISEASE : Individuals capable understanding consent exclude . HEALTHY VOLUNTEERS : Healthy volunteer unable participate treat psychotropic medication within three month prior scan , undergo current psychiatric treatment , history major psychiatric disorder , first degree relative schizophrenia , family history PD .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2, 2016</verification_date>
	<keyword>Familial</keyword>
	<keyword>Genetic</keyword>
	<keyword>Symptomatic</keyword>
	<keyword>Equivocally Affected</keyword>
	<keyword>18F-Fluoro-L-dopa</keyword>
	<keyword>O-15 Labelled Water</keyword>
	<keyword>Carbidopa</keyword>
	<keyword>Adult</keyword>
	<keyword>Schizophrenia</keyword>
	<keyword>Parkinson 's Disease</keyword>
	<keyword>PD</keyword>
	<keyword>Parkinson</keyword>
	<keyword>Healthy Control</keyword>
	<keyword>HV</keyword>
	<keyword>Normal Control</keyword>
</DOC>